Life Sciences

Global Leaders in Life Sciences
  • Access to Capital - $1.1 billion in equity capital raised in 2016
  • Liquid Trading Market - More than 6.4 billion Life Sciences shares were traded in 2016 with a total value of $28 billion
  • Analyst Coverage - Four out of five TSX listed Life Sciences companies are covered by an analyst
  • Tailored & Flexible Listing Criteria - Listing criteria focuses on evidence of adequate financing and operational expertise to carry the company forward with its intended development program
  • Growth Potential - TSXV Issuers can graduate to TSX as the company fulfills its growth strategy

Sector Activity at a Glance – YTD February 28, 2017

February 2017TSXVTSXTSXV and TSX
Number of Issuers 85 43 128
QMV (C$) 3,768,899,312 21,019,618,078 24,788,517,390
New Listings 1 - 1
Equity Capital Raised (C$) 45,150,081 14,725,700 59,875,781
Number of Financings 13 3 16
Volume Traded 774,834,113 440,440,696 1,215,274,809
Value Traded (C$) 989,252,435 2,890,470,190 3,879,722,625
# of Trades 329,844 832,026 1,161,870

Sector Information

For more information on Toronto Stock Exchange and TSX Venture Exchange listed companies, please refer to our Current Market Statistics.

Indices

S&P/TSX Capped Health Care Index

Information

To learn more about listing in the Life Sciences sector on TSX/TSXV, please contact:

Michael Kousaie
Head, Business Development, Life Sciences
+1 416 947-6626
michael.kousaie@tsx.com

Business Development - Asia
(86) 1065 05 8011
asia@tsx.com

Business Development - Europe & Africa
emea@tsx.com

Follow us on Twitter: @tsx_tsxv

v x